Comparing isoflurane with tribromoethanol anesthesia for echocardiographic phenotyping of transgenic mice

Journal of the American Association for Laboratory Animal Science

Volumn 45, Issue 4, 2006, Pages 8-13

  Chu, David K ^a   Jordan, Maria C ^a   Kim, Jeanne K ^a   Couto, Marcelo A ^a   Roos, Kenneth P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMETHOL; ISOFLURANE;

ANESTHESIA; ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EVALUATION RESEARCH; FEMALE; HEART EJECTION FRACTION; HEART RATE; HEART VENTRICLE EJECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; MALE; MOUSE; NONHUMAN; PHENOTYPE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TELEMETRY; TRANSGENIC MOUSE; VELOCITY; VELOCITY OF CIRCUMFERENTIAL FIBER SHORTENING;

ANESTHETICS, GENERAL; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ECHOCARDIOGRAPHY; ETHANOL; FEMALE; HEART RATE; ISOFLURANE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE;

ANIMALIA; MUS MUSCULUS;

EID: 33746683118     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 2+ exchanger. J Gen Physiol 109:717-729.
2. Brunson DB. 1997. Pharmacology of inhalation anesthetics, p 29-40. In: Wixon SK, White WJ, Benson GJ, editors. Anesthesia and analgesia in laboratory animals. San Diego: Academic Press.
3. Buetow BS, Chen LI, Maggio-Price L, Swisshelm K. 1999. Peritonitis in nude mice in a xenograft study. Contemp Top Lab Anim Sci 38:47-49.
4. Chaves AA, Weinstein DM, Bauer JA. 2001. Noninvasive echocardiographic studies in mice: influence of anesthetic regimen. Life Sci 69:213-222.
5. Esposito G, Santana LF, Dilly K, Cruz JD, Mao L, Lederer WJ, Rockman HA. 2000. Cellular and functional defects in a mouse model of heart failure. Amer J Physiol 279:H3101-H3112.
6. Gardin JM, Siri FM, Kitsis RN, Edwards JG, Leinwand LA. 1995. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res 76:907-914.
7. Gardner DJ, Davis JA, Weina PJ, Theune B. 1995. Comparison of tribromoethanol, ketamine/acetylpromazine, Telazol/xylazine, pentobarbital, and methoxyflurane anesthesia in HSD:ISR mice. Lab Animal Sci 45:199-204.
8. Gopalan C, Hegade GM, Bay TN, Brown SR, Talcott MR. 2005. Tribromoethanol-medetomidine combination provides a safe and reversible anesthetic effect in Sprague-Dawley rats. Contemp Top Lab Anim Sci 44:7-10.
9. Hart CYT, Burnett JC, Redfield MM. 2001. Effects of Avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Amer J Physiol 281:H1938-H1945.
10. 2+ exchange. Cardiacspecific knockout of NCX1. Circ Res 95:604-611.
11. Hoit BD. 2001. New approaches to phenotypic analysis in adult mice. J Mol Cell Cardiol 33:27-35.
12. Hoit BD. 2004. Murine physiology: measuring the phenotype. J Mol Cell Cardiol 37:377-387.
13. Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA. 1995. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res 77:632-637.
14. Janssen BJA, De Celle T, Debets JJM, Brouns AE, Callahan MF, Smith TL. 2004. Effects of anesthetics on systemic hemodynamics in mice. Amer J Physiol 287:H1618-H1624.
15. Jordan MC, Zheng Y, Ryazantsev S, Rozengurt N, Roos KP, Neufeld EF. 2005. Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Mol Gen Metab 86:233-243.
16. Kaufman MH, Chang D. 2000. Studies of the mechanism of amniotic sac puncture-induced limb abnormalities in mice. Int J Devl Biol 44:161-175.
17. Kiatchoosakun S, Kirkpatrick D, Hoit BD. 2001. Effects of tribromoethanol anesthesia on echocardiographic assessment of left ventricular function in mice. Comp Med 51:26-29.
18. Lieggi CC, Artwohl CE, Leszczynski JK, Rodriguez NA, Fickbohm BL, Frotman JD. 2005. Efficacy and safety of stored and newly prepared tribromoethanol in ICR mice. Contemp Top Lab Anim Sci 44:17-22.
19. National Research Council. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press.
20. Norris ML, Turner WD. 1983. An evaluation of tribomoethanol (TBE) as an anesthetic agent in the Mongolian gerbil (Meriones unguiculatus). Lab Anim 17:324-329.
21. Office of Laboratory Animal Welfare. 2002. Public health service policy on humane care and use of laboratory animals. Bethesda (MD): National Institutes of Health.
22. Papaioannou VE, Fox JG. 1993. Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci 43:189-192.
23. 2+ exchange expression. Biochem Biophys Res Comm 322:1336-1340.
24. Reid WC, Carmichael KP, Srinivas S, Bryant JL. 1999. Pathologic changes associated with the use of tribromoethanol (Avertin) in the Sprague Dawley rat. Lab Anim Sci 49:665-667.
25. 2+ exchanger results in postpartum hypertrophy and heart failure. FASEB J 14:A696.
26. Roth DM, Swaney JS, Dalton ND, Gilpin EA, Ross J. 2002. Impact of anesthesia on cardiac function during echocardiography in mice. Am J Physiol 282:H2134-H2140.
27. Rottman JN, Ni G, Khoo M, Wang Z, Zhang W, Anderson ME, Madu EC. 2003. Temporal changes in ventricular function assessed echocardiographically in conscious and anesthetized mice. J Am Soc Echocardiog 16:1150-1157.
28. Sczesny G, Veihelmann A., Massberg S, Nolte D, Messmer K. 2004. Long-term anaesthesia using inhalatory isoflurane in different strains of mice: the haemodynamic effects. Lab Anim 38:64-69.
29. Takuma S, Suehiro K, Cardinale C, Hozumi T, Yano H, Shimizu J, Mullis-Jansson S, Sciacca R, Wang J, Burkhoff D, Di Tullio MR, Homma S. 2001. Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. Am J Physiol 280:H2364-H2370.
30. Tan TP, Gao XM, Krawczyxzyn M, Feng X, Kiriazis H, Dart AM, Du XJ. 2003. Assessment of cardiac function by echocardiography in conscious and anesthestized mice. J Cardiovasc Pharmacol 42:182-190.
31. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross J. 1996. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94:1109-1117.
32. Thompson JS, Brown SA, Khurdayan A, Zeynalzadedan A, Sullivan PG, Scheff SW. 2002. Early effects of tribromoethanol, ketamine/xylazine, pentobarbital and isoflurane anesthesia on hepatic and lymphoid tissue in ICR mice. Comp Med 52:63-67.
33. United States Department of Agriculture. [Internet]. Policy 3, 3.1-3.5. [cited May 11, 2006] Available at http://www.aphis.usda. gov/ac/policy/policy3. pdf.
34. Wehling-Henricks M, Jordan MC, Roos KP, Deng B, Tidball JG. 2005. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum Mol Genet 14:1921-1933.
35. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, Carretero OA. 1999. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol 277:H1967-H1974.
36. Zeller W, Meier G., Burki K, Panoussis B. 1998. Adverse effects of tribromoethanol as used in the production of transgenic mice. Lab Anim 32:407-413.
37. Zuurbier CJ, Emons VM, Ince C. 2002. Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strain. Am J Physiol 282:H2099-H2105.